A novel MARV glycoprotein-specific antibody with potentials of broad-spectrum neutralization to filovirus
Marburg virus (MARV) is one of the filovirus species that cause deadly hemorrhagic fever in humans, with mortality rates up to 90%. Neutralizing antibodies represent ideal candidates to prevent or treat virus disease. However, no antibody has been approved for MARV treatment to date. In this study,...
Main Authors: | , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
eLife Sciences Publications Ltd
2024-03-01
|
Series: | eLife |
Subjects: | |
Online Access: | https://elifesciences.org/articles/91181 |